A$0.08 0.0 0.0%
Last Trade - 04/12/19
| Market Cap | £14.7m |
| Enterprise Value | £12.2m |
| Revenue | £6.80m |
| Position in Universe | 1091st / 1833 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | TTM | 2020E | 2021E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|---|
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2020
|
31st Dec 2021
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Asian American Medical Group Limited is engaged in the provision of specialized medical services for liver diseases and transplantation, radiation oncology and healthcare project management and consultancy services. The Company's segments include liver, radiation oncology, management and consultancy, and others. The liver segment is engaged in the provision of medical consultation and services in the hepatology and related fields. The radiation oncology segment is engaged in the provision of medical consultation and services in the radiation oncology and related fields. The management and consultancy segment is engaged in the provision of healthcare management and consultancy services. Its operations include the Asian American Liver Centre Pte Ltd (AALC) and the Asian American Radiation Oncology Pte Ltd (AARO). AALC offers both inpatient and outpatient facilities, as well as services for international patients. AARO clinical provides sub-specialty radiation oncology care.
| Last Annual | August 31st, 2019 |
| Last Interim | August 31st, 2019 |
| Incorporated | February 11, 2000 |
| Public Since | March 19, 2007 |
| No. of Shareholders: | n/a |
| No. of Employees: | 15 |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | |
| Exchange | Australian Stock Exchange - SEATS |
| Shares in Issue | 347,752,754 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 6A Napier Road,Gleneagles Hospital # 02 36A 36B/37, 258500, Singapore |
| Web | https://www.aamg.co/ |
| Phone | +65 6 4762088 |
| Contact | () |
| Auditors | BDO Audit (SA) Pty Ltd |
